SANUWAVE Health, Inc. (SNWV) Financial Analysis & Valuation | Quarter Chart
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resu... more
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes non... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $50.26M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Morgan C. Frank |
| IPO Date | 2024-10-18 | CAGR | — |
| Employees | 55 | Website | www.sanuwave.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
SNWV chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $83.46M | P/E | 24.35 | Forward P/E | — | PEG | — |
| P/S | 0.01 | P/B | 0.02 | P/CF | 0.01 | P/FCF | 0.01 |
| Sales | $43.90M | Sales 1Y | 12.02% | Sales 3Y | 142.34% | Sales 5Y | 432.18% |
| EPS | $0.24 | EPS 1Y | -108.64% | EPS 3Y | -105.22% | EPS 5Y | -102.88% |
| Sales QoQ | 1.25% | EPS QoQ | -52.94% | Sales QoQ Avg | 0.43% | EPS QoQ Avg | 3719.12% |
| Gross Margin | 75.2% | Operating Margin | 1.54% | Profit Margin | 32.6% | ROCE | 3.68% |
| ROA | 39% | ROE | 1728% | Altman Z Score | -5.47 | Piotroski Score | 4 |
| Current Ratio | 1.28 | Quick Ratio | 0.89 | Cash Ratio | 0.52 | Op. CF Ratio | 0.05 |
| Debt/Equity | 2.56 | Debt/Assets | 0.19 | Lt Debt/Equity | 0.55 | Lt Debt/Cap. | 0.35 |
| Intrst Cov. | 0.19 | Inventory Turnover | 1.54 | Asset Turnover | 1.2 | Receivables Turnover | 7.57 |
| Enterprise Value | $83.46M | P/E Ratio | 24.35 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.01 | P/B Ratio | 0.02 |
| P/CF Ratio | 0.01 | P/FCF Ratio | 0.01 |
| EPS | $0.24 | EPS Growth 1Y | -108.64% |
| EPS Growth 3Y | -105.22% | EPS Growth 5Y | -102.88% |
| Revenue Growth 1Y | 12.02% | Gross Margin | 75.2% |
| Operating Margin | 1.54% | Profit Margin | 32.6% |
| ROE | 1728% | ROA | 39% |
| ROCE | 3.68% | Current Ratio | 1.28 |
| Quick Ratio | 0.89 | Cash Ratio | 0.52 |
| Debt/Equity | 2.56 | Interest Coverage | 0.19 |
| Altman Z Score | -5.47 | Piotroski Score | 4 |
SANUWAVE Health, Inc. (SNWV) valuation & financials
SANUWAVE Health, Inc. (SNWV) has a market capitalization of $50.26M and trades at a price-to-earnings ratio of 24.4. It operates in the Healthcare sector (Medical - Devices).
SANUWAVE Health, Inc.'s revenue grew +12.0% over the last year.
SANUWAVE Health, Inc.'s next earnings report is scheduled for November 6, 2026 (provider scheduled date); analysts estimate EPS of $0.01. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)